Cabinet Medical Van Houte Cornejo Montero

At Cabinet Medical Van Houte Cornejo Montero in Yvoir, clinical trials in oncology focus on major cancers such as non-small cell lung cancer and metastatic renal cell carcinoma. These studies are designed to evaluate whether new treatment strategies can improve survival and disease control compared with current standard care.

• Testing whether immunotherapy can help prevent recurrence after surgery for early-stage lung cancer
• Comparing treatment approaches for metastatic renal cell carcinoma to improve survival outcomes

This research reflects a strong interest in advancing cancer care through better use of immune-based therapies and other targeted treatment options.

The site's pneumology program includes trials in respiratory medicine for conditions such as progressive fibrosing interstitial lung diseases. The aim is to assess whether new therapies can slow lung function decline and improve outcomes for people with chronic, worsening lung disease.

• Evaluating a new treatment for progressive fibrosing interstitial lung diseases
• Measuring changes in lung function to understand treatment benefit

This work highlights the clinic's role in studying therapies that may help preserve breathing capacity and quality of life in patients with serious interstitial lung disease.

In addition to solid tumors and lung disease, the site is involved in studies of acute lymphoblastic leukemia in older adults. These trials are focused on finding safer and more effective treatment options for patients who may need gentler approaches because of age or overall health.

• Assessing a treatment strategy for newly diagnosed Philadelphia-negative B-cell precursor acute lymphoblastic leukemia
• Comparing event-free survival and overall survival with alternative treatment approaches

The research portfolio also includes work that is not limited to a single disease area, showing a broader effort to refine cancer therapy and support better treatment selection across different patient groups.